Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.73 -0.22 (-0.18%)
Streaming Delayed Price Updated: 10:11 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
40 41 Next >
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABT
From The Rosen Law Firm, P.A.
Via Business Wire
ABBOTT LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
From Kahn Swick & Foti, LLC
Via Business Wire
ABBOTT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
FDA Approves Abbott's New Spinal Cord Stimulation Device For Pain
Via Benzinga
FDA Stops UK-Based Company's Baby Formula Imports Accusing Altered Paperwork: Report
Via Benzinga
EQUITY ALERT: Rosen Law Firm Encourages Abbott Laboratories Investors to Inquire About Class Action Investigation – ABT
From The Rosen Law Firm, P.A.
Via Business Wire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABT
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
Growing Adoption Of This Company's Technologies Could Reportedly Prevent Alcohol Abuse in Workplaces
SOBR Safe Inc. (NASDAQ: SOBR) reports helping to fight a growing alcohol addiction in the workplace. 
Via Benzinga
There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
For people suffering from any type of addiction, getting the best medical care can make a significant difference in their journey to recovery. In the case of alcohol abuse, for example, the talk about... 
Via Benzinga
With Alcohol Abuse On The Rise, Could This Company's Virtual and Remote Rehabilitation Program Help?
For centuries, the consumption of alcoholic beverages has played an important social role in many cultures. While it can fuel excitement during personal moments or at gatherings, excessive use can be... 
Via Benzinga
3 Blowout Earnings Reports That Could Mark Turning Points
Based on the market’s reactions, we could someday look back at Q2 earnings as a major inflection point for these three stocks. 
Via MarketBeat
Topics Earnings
Exposures Financial
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
Diversification is the edge for any portfolio. Rising inflation is impacting discretionary consumer spending as households try to stretch their wallets. 
Via MarketBeat
Topics Artificial Intelligence Earnings Economy
Exposures Artificial Intelligence Economy Financial
MedTech Giant Abbott To Inject Over €400M In Ireland To Expand Production Of Glucose Monitoring Tech
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,500 Today
  Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.78% on an annualized basis producing an average annual return of 13.29%. Currently, Abbott Laboratories has a... 
Via Benzinga
Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Via Benzinga
The 3 Best Vanguard Funds to Buy in August
VCR, VHT and VYM are among the best Vanguard funds to buy now. Here is why they will make great investments in the coming months. 
Via InvestorPlace
This Is What Whales Are Betting On Abbott Laboratories
Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Is Senseonics (SENS) Stock Heating Up Today?
A big insurer's approval of Senseonomics' Eversense is a big opportunity, but SENS stock still faces scaled competitors. 
Via InvestorPlace
CNBC's Final Trades: Air Products & Chemicals, TJX Companies, Qualcomm And This Healthcare Stock
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management chose Air Products & Chemicals, Inc. (NYSE: APD). 
Via Benzinga
Target And Chevron Get CNBC Fast Money Mentions With Joe Terranova Rebalancing His ETF
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Can This Company's Tech Help Businesses Reduce Insurance Premiums From Alcohol-Related Injuries?
Photo by Kindel Media from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Use These To Find Your Stock’s Support and Resistance Levels
A stock is a trading and investing instrument representative of an underlying business but surprisingly gets too often misunderstood in a bear market. 
Via MarketBeat
7 Blue-Chip Stocks to Buy Before the Bull Market Returns
Investors have many beat-up blue chip stocks that are trading at steep discounts today, giving plenty of margin of safety. 
Via InvestorPlace
Analyzing Abbott Laboratories's Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 9.33% since its last report. The company recently reported that it has 14.22 million shares sold short, which... 
Via Benzinga
A Wearable Band To Help Fight Addictions? This Company's Tech Could Transform The Industry
In October 2020, a New York bus driver was slapped with multiple criminal charges after it was discovered that she drove students while drunk and stopped at McDonald’s Corp. (NYSE: MCD) 
Via Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
Reuters Monkeypox Emergency Could Last Months, According To Experts 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.